000 | 01379 a2200445 4500 | ||
---|---|---|---|
005 | 20250511165848.0 | ||
264 | 0 | _c19750621 | |
008 | 197506s 0 0 eng d | ||
022 | _a0022-2623 | ||
024 | 7 |
_a10.1021/jm00238a003 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWechter, W J | |
245 | 0 | 0 |
_aara-Cytidine acylates. Use of drug design predictors in structure-activity relationship correlation. _h[electronic resource] |
260 |
_bJournal of medicinal chemistry _cApr 1975 |
||
300 |
_a339-44 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAcylation |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCytarabine _xanalogs & derivatives |
650 | 0 | 4 |
_aEsterases _xblood |
650 | 0 | 4 | _aEsters |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHydrolysis |
650 | 0 | 4 | _aKinetics |
650 | 0 | 4 |
_aLeukemia L1210 _xdrug therapy |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred Strains |
650 | 0 | 4 | _aSolubility |
650 | 0 | 4 | _aStructure-Activity Relationship |
650 | 0 | 4 |
_aSynovial Fluid _xenzymology |
700 | 1 | _aJohnson, M A | |
700 | 1 | _aHall, C M | |
700 | 1 | _aWarner, D T | |
700 | 1 | _aBerger, A E | |
700 | 1 | _aWenzel, A H | |
700 | 1 | _aGish, D T | |
700 | 1 | _aNeil, G L | |
773 | 0 |
_tJournal of medicinal chemistry _gvol. 18 _gno. 4 _gp. 339-44 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1021/jm00238a003 _zAvailable from publisher's website |
999 |
_c1127702 _d1127702 |